ItHome Hypertension Blood Pressure Drug Litigation Sees Some Warranty Claims Advance

Blood Pressure Drug Litigation Sees Some Warranty Claims Advance

Credits to the 👉🏾Source Link👉🏾 Olivia
Julie Steinberg

Patients and insurers alleging that recalled generic valsartan blood pressure drugs were tainted with probable carcinogens may proceed with many of their warranty claims, the federal court overseeing multidistrict litigation said.

Plaintiffs say the drugs are tainted with the industrial byproducts NDMA and NDEA. The MDL includes individual personal injury suits alleging the drug caused cancer, and proposed class suits.

They raise about three dozen claims on behalf of hundreds of individuals, as well as would-be statewide and nationwide classes of consumers against more than 40 defendants including manufacturers, wholesalers, and pharmacies. There are three separate master complaints seeking personal…

Source Link

related posts

Leave a Comment

This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More

%d bloggers like this: